Reportedly, the airport is equipped with Asia's largest temperature-controlled export pharmaceutical excellence centre.
Mumbai's Chhatrapati Shivaji Maharaj International Airport is all set to assign a task force for the advance planning and collaboration between the airport and stakeholders, pertaining to the management of the upcoming COVID-19 vaccine. This would include airline customers, supply chain partners, regulatory and governmental bodies and vaccine distributors. Further, the airport has set aside a temperature-controlled centre with an annual handling capacity of 350,000 tonnes.
Cold chain to be created for the movement of the COVID-19 vaccine
A cold chain will be created for the coronavirus vaccine movement from the manufacturing facility to the end distributor. The assigned task force will take care of the temperature and dwell time with special approval from regulators. According to reports, flexible slots for ad hoc charter operations may play an important role in storage and transportation of the vaccine. The airport is also slated to set up a 24-hour customer service cell, dedicated to the queries related to the import and export of the COVID-19 vaccine.
Asia's largest temperature-controlled export pharmaceutical excellence centre
Reportedly, the airport is equipped with Asia's largest temperature-controlled export pharmaceutical excellence centre with a handling capacity of 350,000 tonnes per year. The 4,000 sqm centre comprises of a total of about 140 unit load device (ULD) storage positions and approximately 50 power outlets for charging active containers. The airport will even organize for six truck docks for the cargo management, two release gates, two x-ray machines, six cold chambers, CCTV, electronic temperature management system with alarm alerts and back-up.